Meso-Zeaxanthin
Meso-Zeaxanthin
A macular carotenoid that protects the center of the retina from blue light damage and oxidative stress, supporting eye health and visual function.
Meso-Zeaxanthin is one of three carotenoids that make up the macular pigment in the eye (along with lutein and zeaxanthin). It's concentrated in the very center of the macula (fovea) where visual acuity is highest. Unlike lutein and zeaxanthin which come from diet, meso-zeaxanthin is primarily converted from lutein in the retina or must be supplemented directly. It provides critical protection against blue light and oxidative damage.
Mechanisms of Action
Blue Light Filtration
Absorbs harmful blue light
Antioxidant Protection
Neutralizes oxidative stress in retina
Foveal Protection
Concentrated at visual center
Recommended Dose
10mg daily (often in combination with lutein and zeaxanthin)
Loading: Not required; consistent daily intake is key
Optimal Timing
- With a fat-containing meal
- Any time of day
Take with food
Best Form
Meso-zeaxanthin with lutein and zeaxanthin (MPOD formula)
Alternatives: Standalone meso-zeaxanthin
Most effective when combined with lutein (10mg) and zeaxanthin (2mg) in a 10:10:2 ratio. Look for products that specify meso-zeaxanthin content.
Duration
Minimum: 12 weeks
Optimal: 24 weeks
Cycling: Not required
Note: Fat-soluble carotenoid; absorption significantly improved with dietary fat. Takes months to build up macular pigment.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Increased Macular Pigment
Higher macular pigment optical density
Improved Visual Function
Better contrast sensitivity and glare recovery
Macular Protection
Reduced risk of macular degeneration progression
Strong evidence for slowing progression when combined with other macular carotenoids
May help protect against blue light exposure
Who Should NOT Take This
- Known allergy or hypersensitivity to Meso-Zeaxanthin or related compounds
Drug Interactions
Fat-soluble carotenoid; take with meals containing fat for absorption
Possible Side Effects
Tip: Harmless and reversible; reduce dose if concerned
Warnings
- Takes months to significantly increase macular pigment
- Should be combined with lutein and zeaxanthin for best results
Top studies from 40+ peer-reviewed papers
Liu R et al. âĒ Advances in Nutrition (2024)
âAll intervention groups including L+Z+MZ significantly increased MPOD compared to placebo.â
Key Findings:
- Network meta-analysis of RCTs
- Triple carotenoid combination most effective
- Improved visual function outcomes
Ranard KM et al. âĒ Advances in Nutrition (2021)
â>10 mg/day of lutein/zeaxanthin can increase MPOD; greater effects seen with meso-zeaxanthin.â
Key Findings:
- 46 studies with 3189 participants analyzed
- Significant MPOD increase at 5-20mg/day
- Dose-response relationship confirmed
Lem DW et al. âĒ Nutrients (2021)
âThe data suggest that carotenoid vitamin therapy exerts synergic neuroprotective benefits and has the capacity to serve adjunctive therapy in the management of glaucoma.â
Key Findings:
- A comprehensive literature search was conducted in three databases (PubMed, Cochrane Library, and Web of Science) and 20 records were identified for screening.
- Lutein demonstrated enhanced neuroprotection on retinal ganglion cell survival and preserved synaptic activity.
- In clinical studies, a protective trend was seen with greater dietary consumption of carotenoids and risk of glaucoma, while greater carotenoid levels in macular pigment were largely associated with improved visual performance in glaucomatous eyes.
- The data suggest that carotenoid vitamin therapy exerts synergic neuroprotective benefits and has the capacity to serve adjunctive therapy in the management of glaucoma.
Lem DW et al. âĒ Nutrients (2021)
âThese findings provide a strong molecular basis and a line of evidence that suggests carotenoid vitamin therapy may offer enhanced neuroprotective effects with therapeutic potential to function as an adjunct nutraceutical strategy for management of diabetic retinopathy.â
Key Findings:
- Lutein and zeaxanthin demonstrated significant protection against capillary cell degeneration and hyperglycemia-induced changes in retinal vasculature.
- Observational studies indicate that depletion of xanthophyll carotenoids in the macula may represent a novel feature of DR, specifically in patients with type 2 or poorly managed type 1 diabetes.
- Meanwhile, early interventional trials with dietary carotenoid supplementation show promise in improving their levels in serum and macular pigments concomitant with benefits in visual performance.
- These findings provide a strong molecular basis and a line of evidence that suggests carotenoid vitamin therapy may offer enhanced neuroprotective effects with therapeutic potential to function as an adjunct nutraceutical strategy for management of diabetic retinopathy.
Arunkumar R et al. âĒ Biochimica et biophysica acta. Molecular and cell biology of lipids (2020)
âAll rights reserved.â
Key Findings:
- The MP carotenoids filter high-intensity, short-wavelength visible light and are powerful antioxidants in a region vulnerable to light-induced oxidative stress.
- This review focuses on MP chemistry, absorption, metabolism, transport, and distribution with special emphasis on animal models used for MP study.
- This article is part of a Special Issue entitled Carotenoids recent advances in cell and molecular biology edited by Johannes von Lintig and Loredana Quadro.Copyright ÂĐ 2020 Elsevier B.V.
- All rights reserved.
Study Type Distribution
Goals This Supplement Supports
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.